SXTC.NASDAQ
- China SXT Pharmaceuticals
(Financial Status)
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
Valuation Estimation |
EPS (Current/Estimated)
-3.57/--
|
Enterprise Value
1.95M
|
Balance Sheet |
Book Value Per Share
4.01
|
Cash Flow |
Cash Flow Yield
--
|
Income Statement |
Total Revenue
1.93M
|
Operating Revenue Per Share
0.57
|
Industry Comparison
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
Quotes are at least 15-min delayed:2024/11/10 17:13 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
|
|||
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China. |